CART-19/BCMA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CART-19/BCMA, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT [Phase 1, Phase 2]